Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$3.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 7 most recent Form 4 transactions.
| Zenas BioPharma, Inc. |
| PBUY |
| 60,000 |
| $16.88 |
| $1M |
| +162.5% |
| Open the original filing on SEC.gov |
| Apr 29 | ZBIO | Zenas BioPharma, Inc. | PBUY | 35,000 | $17.62 | $616.7K | +2.0% | Open the original filing on SEC.gov |
| Apr 28 | ZBIO | Zenas BioPharma, Inc. | PBUY | 25,000 | $18.02 | $450.5K | +1.5% | Open the original filing on SEC.gov |
| Mar 31 | ZBIO | Zenas BioPharma, Inc. | PBUY | 34,000 | $19.31 | $656.5K | +2.0% | Open the original filing on SEC.gov |
| Mar 30 | ZBIO | Zenas BioPharma, Inc. | PBUY | 20,000 | $18.23 | $364.6K | +1.2% | Open the original filing on SEC.gov |